Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 2 2Phase 1/2 2Phase 2/3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 2

Interventions

Temozolomide 7Radiotherapy 6Bevacizumab 5Magnetic Resonance Spectroscopy 3ribociclib 2olaparib 2fluorodopa F 18 2fluciclovine F-18 2atezolizumab 2abemaciclib 2Surgical Procedures, Operative 2Specimen Handling 2Radiation 2Ketoconazole 2Everolimus 2Disulfiram 2Carvedilol 2zimberelimab 1tinostamustine 1temsirolimus 1senicapoc 1sacituzumab govitecan 1posaconazole 1pitavastatin 1perampanel 1pamiparib 1palbociclib 1niraparib 1mycophenolic adenine dinucleotide 1lorlatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Glioblastoma × Disulfiram × Clear all
NCT03151772 2020-09-28

INSIDE

Sahlgrenska University Hospital

Phase EARLY_PHASE1 Terminated
3 enrolled
CNS

Glioblastoma

NCT01907165 2018-07-20

Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
21 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡